1. Walker BR, Colledge NR, Ralston S, Penman ID, Britton R, editors. Davidson’s principles and practice of medicine. 22nd edition. Edinburgh ; New York: Churchill Livingstone/Elsevier; 2014. 1372 p.
2. Vlahos AP, Koutsouka FP, Papamichael ND, Makis A, Baltogiannis GG, Athanasiou E, et al. Determinants of Pulmonary Hypertension in Patients with Beta-Thalassemia Major and Normal Ventricular Function. Acta Haematol. 2012;128(2):124–9.
3. Cecil RL, Goldman L, Schafer AI, editors. Goldman’s Cecil medicine. 24th ed. Philadelphia: Elsevier/Saunders; 2012. 2569 p.
4. Du Z-D, Roguin N, Milgram E, Saab K, Koren A. Pulmonary hypertension in patients with thalassemia major. Am Heart J. 1997 Sep;134(3):532–7.
5. Derchi G, Fonti A, Forni GL. Pulmonary hypertension in patients with thalassemia major. Am HEART J. 1999;138(2):384.
6. El-Beshlawy A, Youssry I, El-Saidi S, El Accaoui R, Mansi Y, Makhlouf A, et al. Pulmonary hypertension in β-thalassemia major and the role of l-carnitine therapy. Pediatr Hematol Oncol. 2008 Jan;25(8):734–43.
7. Meloni A, Detterich J, Pepe A, Harmatz P, Coates TD, Wood JC. Pulmonary hypertension in well-transfused thalassemia major patients. Blood Cells Mol Dis Blood Cells Mol Dis. 2015;54(2):189–94.